Assessing the Benefits and Harms of RNAi-Based Pesticides Through the Lens of Islamic Bioethics
Document Type
Article
Publication Date
4-1-2026
Abstract
RNA interference (RNAi)–based pesticide technology is an alternative to synthetic pesticides or transgenic plants that are able to control, repel, or eliminate pests that could cause harm to crops or livestock. A notable example is Calantha™, the first commercially approved sprayable RNAi biopesticide, which received approval from the US Environmental Protection Agency (EPA) in 2024. Although RNAi technology holds promise with many potential benefits, there are still uncertainties about potential risks to humans and the environment. This study applies the Maslahah-Mafsadah (benefit-harm) framework from Maqasid al-Shari’ah (Islamic bioethics) to evaluate RNAi-based pesticides, analysing their implications through evidence-based, impact-based, and priority-based approaches. By addressing universal bioethical principles such as beneficence and non-maleficence, this study highlights how Islamic bioethical concepts can contribute to broader ethical discussions on emerging biotechnologies. The analysis considers pest management, environmental sustainability, human health, and socio-economic impacts, concluding that RNAi-based pesticides may be categorised as zanniyyah (probable) in terms of their benefits and risks. Consequently, the study underscores the ethical obligation to establish rigorous regulatory oversight, taking into considerations appropriate scientific evidence, environmental impact studies, and health assessments when evaluating the technology.
Keywords
Benefit, Harm, Islamic bioethics, Maqasid al-Shari’ah, RNAi-based pesticide
Publication Title
Asian Bioethics Review
ISSN
1793-8759
DOI
10.1007/s41649-025-00370-4
Recommended Citation
Muhammad, Muhammad Faiz; Harun, Muhammad Safwan; and Mat Jalaluddin, Nurzatil Sharleeza, "Assessing the Benefits and Harms of RNAi-Based Pesticides Through the Lens of Islamic Bioethics" (2026). Research Publications (2026 to 2030). 779.
https://knova.um.edu.my/research_publications_2026_2030/779
Volume
18
Issue
2
First Page
449
Last Page
469
Publisher
Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore